BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12508174)

  • 21. Comparison of immunocytochemical sensitivity between formalin-fixed and alcohol-fixed specimens reveals the diagnostic value of alcohol-fixed cytocentrifuged preparations in malignant effusion cytology.
    Ikeda K; Tate G; Suzuki T; Mitsuya T
    Am J Clin Pathol; 2011 Dec; 136(6):934-42. PubMed ID: 22095380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions.
    Chen CJ; Chang SC; Tseng HH
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Sep; 54(3):149-55. PubMed ID: 7954054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV; Nesland JM; Davidson B
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of the thromboplastin-plasma cell-block technique for fine-needle aspiration and serous effusions.
    Kulkarni MB; Desai SB; Ajit D; Chinoy RF
    Diagn Cytopathol; 2009 Feb; 37(2):86-90. PubMed ID: 19021217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mesothelial cell. Cytology. Cytochemistry. Immunocytochemistry. Contribution of immunolabelling to the cytodiagnosis of serous effusions with cells of mesothelial aspect].
    Marsan C; Gaulier A; Sabatier P; Garcia R
    Arch Anat Cytol Pathol; 1993; 41(5-6):223-8. PubMed ID: 8135583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions.
    Grefte JM; de Wilde PC; Salet-van de Pol MR; Tomassen M; Raaymakers-van Geloof WL; Bulten J
    Acta Cytol; 2008; 52(1):35-44. PubMed ID: 18323273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY; Li GD; Liu HB; Jiang LL
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytochemical staining on ThinPrep processed smears.
    Leung SW; Bédard YC
    Mod Pathol; 1996 Mar; 9(3):304-6. PubMed ID: 8685232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
    Davidson B; Risberg B; Kristensen G; Kvalheim G; Emilsen E; Bjåmer A; Berner A
    Virchows Arch; 1999 Jul; 435(1):43-9. PubMed ID: 10431845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
    Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
    Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of clot examination for malignant cells in serous effusions.
    Jalal R; Aftab K; Hasan SH; Pervez S
    Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of commonly used immunostains on cell-transferred cytologic specimens.
    Gong Y; Joseph T; Sneige N
    Cancer; 2005 Jun; 105(3):158-64. PubMed ID: 15852338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usefulness of AgNOR technique in the interpretation of serous effusions].
    Rocher AE; Blanco AM; Palaoro LA
    Rev Med Chil; 2000 Sep; 128(9):963-8. PubMed ID: 11349500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytopathology of exocrine pancreatic carcinoma in effusions.
    Di Bonito L; Dudine S; Falconieri G
    Acta Cytol; 1991; 35(3):311-4. PubMed ID: 1710404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic role of claudins in serous effusions.
    Kleinberg L; Holth A; Fridman E; Schwartz I; Shih IeM; Davidson B
    Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
    Dejmek A; Hjerpe A
    Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
    Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T
    Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3.
    Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J
    Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.